Joshua Blight

Chief Executive Officer & Co-Founder, Baseimmune

Josh has a PhD in Vaccinology and Infectious Diseases from the Jenner Institute at the University of Oxford where he pioneered computational approaches to design vaccines against various infectious diseases. He’s designed a number of vaccines against diseases such as dengue and chikungunya to human papilloma virus (HPV) and malaria. Two of his vaccine candidates are currently in human clinical trials and licensed to pharma. For the last three years he worked as a postdoctoral research associate at Imperial College London, developing new ways to create malaria vaccines. In 2019 he co-founded Baseimmune to generate mutation-proof vaccines through deep learning technology.

Leonardo Royal Hotel London Tower Bridge

16 May 2023

The Mermaid, London

16 November 2023